Trailing-twelve-month (TTM) revenue is $11.48 Billion with a year-over-year growth of +26.23%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $2,675,800,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-22 |
| Q4 FY2025Period ended 2025-12-31 | $2,880,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-13 |
| Q1 FY2026Period ended 2026-03-31 | $2,649,500,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-22 |
| Q2 FY2026Period ended 2026-06-30 | $3,274,300,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-29 |
| TTM revenue | $11,479,600,000 |
Current P/S: $97,363,462,850 market capitalization ÷ $11,479,600,000 TTM revenue = 8.48x.
Market capitalization source: FMP quote. Quote observed 2026-09-21T19:15:28.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $3.27B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-21T19:16:37.565Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Product | $3.3B | $3.9B | $4.3B | $5.4B | $6.4B | $8.4B |
| Service | $1.1B | $1.1B | $1.4B | $1.5B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Americas Segment | N/A | N/A | N/A | $3.9B | $4.6B | $6.4B |
| Asia | $1.4B | $1.6B | $1.5B |
$11.48B
$11.48 Billion
+26.23%
vs. $9.09B a year ago (TTM)
+18.93%
5 Year compound annual growth rate
1 Year
+26.23%
3 Year
+21.55%
5 Year
+18.93%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $10.23B | +$2.22B | +27.69% |
| 2024 | $8.01B | +$1.15B | +16.74% |
| 2023 | $6.86B | +$1.17B | +20.59% |
| 2022 | $5.69B | +$693.40M | +13.87% |
| 2021 | $5.00B | +$627.50M | +14.36% |
| 2020 |
TTM Growth
+26.23%
3-Year CAGR
+21.55%
5-Year CAGR
+18.93%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 27 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-21T19:16:37.565Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $1.8B |
| N/A |
| N/A |
| Asia Pacific Segment | N/A | N/A | N/A | $1.6B | $1.9B | $2.3B |
|---|
| CHINA | $779M | N/A | N/A | N/A | N/A | N/A |
|---|
| EMEA Segment | N/A | N/A | N/A | $1.7B | $2.3B | $2.4B |
|---|
| Europe | $777M | $1.0B | $1.1B | N/A | N/A | N/A |
|---|
| Latin America | $181M | $264M | $308M | N/A | N/A | N/A |
|---|
| Middle East And Africa | $189M | $187M | $187M | N/A | N/A | N/A |
|---|
| UNITED STATES | $1.8B | N/A | N/A | N/A | N/A | N/A |
|---|
| United States And Canada | $1.9B | $2.0B | $2.5B | N/A | N/A | N/A |
|---|
| $4.37B |
| ($60.60M) |
| (1.37%) |
| 2019 | $4.43B | +$145.60M | +3.40% |
| 2018 | $4.29B | +$406.20M | +10.47% |
| 2017 | $3.88B | ($64.10M) | (1.63%) |
